Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Newamsterdam Pharma Company ORDINARY SHARES | 10,719,110 | 10,719,110 | 0 | $275.48M | $219.42M | 32.46% | -$56.06M |
| Nuvalent Inc | 1,447,267 | 1,447,267 | 0 | $113.29M | $102.64M | 15.19% | -$10.65M |
| Pharvaris N V COM | 3,303,381 | 3,303,381 | 0 | $63.33M | $51.86M | 7.67% | -$11.46M |
| Disc Medicine, Inc.(IRON) | 983,500 | 983,500 | 0 | $62.35M | $48.82M | 7.22% | -$13.53M |
| Dianthus Therapeutics, Inc.(DNTH) | 2,689,707 | 2,689,707 | 0 | $58.64M | $48.79M | 7.22% | -$9.84M |
| Savara Inc.(SVRA) | 14,565,457 | 17,600,621 | +3,035,164 | $44.72M | $48.75M | 7.21% | +$4.04M |
| Solid Biosciences Inc | 4,034,582 | 7,911,669 | +3,877,087 | $16.14M | $29.27M | 4.33% | +$13.13M |
| Olema Oncology, Inc.(OLMA) | 7,470,214 | 6,843,954 | -626,260 | $43.55M | $25.73M | 3.81% | -$17.82M |
| Rapid Micro Biosystems, Inc.CL A(RPID) | 8,434,560 | 8,434,560 | 0 | $7.59M | $22.27M | 3.29% | +$14.68M |
| Cidara Therapeutics Inc | 703,080 | 703,080 | 0 | $18.90M | $15.14M | 2.24% | -$3.75M |
| Upstream Bio, Inc.(UPB) | 2,295,322 | 2,295,322 | 0 | $37.74M | $14.05M | 2.08% | -$23.69M |
| Annexon, Inc.(ANNX) | 5,249,069 | 5,249,069 | 0 | $26.93M | $10.13M | 1.50% | -$16.80M |
| Atea Pharmaceuticals, Inc.(AVIR) | 2,485,638 | 2,485,638 | 0 | $8.33M | $7.43M | 1.10% | -$894.8K |
| Kyverna Therapeutics, Inc.(KYTX) | 3,368,370 | 3,368,370 | 0 | $12.60M | $6.50M | 0.96% | -$6.10M |
| X4 Pharmaceuticals, Inc.(XFOR) | 16,915,784 | 16,915,784 | 0 | $12.41M | $4.00M | 0.59% | -$8.41M |
| Cabaletta Bio, Inc.(CABA) | 2,760,888 | 2,760,888 | 0 | $6.27M | $3.82M | 0.57% | -$2.44M |
| Tango Therapeutics, Inc.(TNGX) | 2,712,008 | 2,712,008 | 0 | $8.38M | $3.72M | 0.55% | -$4.66M |
| Xilio Therapeutics, Inc.(XLO) | 4,566,817 | 4,566,817 | 0 | $4.36M | $3.31M | 0.49% | -$1.05M |
| Mersana Therapeutics Inc | 8,663,673 | 8,663,673 | 0 | $12.39M | $2.98M | 0.44% | -$9.41M |
| Century Therapeutics, Inc.(IPSC) | 5,410,361 | 5,410,361 | 0 | $5.46M | $2.58M | 0.38% | -$2.89M |
| C4 Therapeutics, Inc.(CCCC) | 1,111,910 | 1,111,910 | 0 | $4.00M | $1.78M | 0.26% | -$2.22M |
| Invivyd, Inc.(IVVD) | 1,799,595 | 1,799,595 | 0 | $797.4K | $1.09M | 0.16% | +$291.9K |
| Nautilus Biotechnology, Inc.(NAUT) | 1,759,000 | 1,072,421 | -686,579 | $2.96M | $923.4K | 0.14% | -$2.03M |
| Newamsterdam Pharma CompanyW EXP 99 99 999 *W EXP 99/99/999 | 100,000 | 100,000 | 0 | $1.43M | $899.0K | 0.13% | -$526.0K |
| Marinus Pharmaceuticals Inc | 2,693,380 | 0 | -2,693,380 | $1.44M | $0 | — | -$1.44M |
| Syros Pharmaceuticals Inc | 2,750,151 | 0 | -2,750,151 | $632.0K | $0 | — | -$632.0K |